Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-22

FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s supplemental application for Naproxen and Esomeprazole Magnesium (ANDA 213699), establishing a generic Naproxen/Esomeprazo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen and Esomeprazole Magnesium (Naproxen and Esomeprazole Magnesium)

Snippet

SUPPL AP for NAPROXEN AND ESOMEPRAZOLE MAGNESIUM (NAPROXEN AND ESOMEPRAZOLE MAGNESIUM)